Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,445,887
  • Shares Outstanding, K 50,683
  • Annual Sales, $ 967,580 K
  • Annual Income, $ 55,020 K
  • 60-Month Beta 0.74
  • Price/Sales 5.77
  • Price/Cash Flow 23.77
  • Price/Book 9.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.76
  • Number of Estimates 4
  • High Estimate 0.82
  • Low Estimate 0.73
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +20.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.87 +0.54%
on 01/24/20
118.40 -9.25%
on 12/26/19
-10.78 (-9.12%)
since 12/24/19
3-Month
106.87 +0.54%
on 01/24/20
130.75 -17.82%
on 11/01/19
-12.74 (-10.60%)
since 10/24/19
52-Week
80.24 +33.92%
on 04/18/19
140.36 -23.45%
on 08/19/19
+10.11 (+10.39%)
since 01/24/19

Most Recent Stories

More News
After Yesterday's Decline of 1.41%, Haemonetics Corp Offers Investors Better Value

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $108.30 to a high of $109.28. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $109.59...

HAE : 107.45 (-2.37%)
New Product Suite Boosts Intersect ENT Despite Cost Concerns

With respect to Intersect ENT's (XENT) Propel line, the PROPEL suite scores as the standard of care for polyp patients undergoing sinus surgery.

XENT : 24.79 (-0.96%)
MDT : 119.26 (-1.41%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
Zimmer (ZBH) Stock Hits New 52-Week High: What's Driving It?

Zimmer (ZBH) is optimistic about maintaining its growth momentum on several recent developments.

HRC : 109.64 (-2.81%)
ZBH : 147.80 (-1.14%)
HAE : 107.45 (-2.37%)
MYO : 0.32 (-3.03%)
Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark

We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.

ABT : 90.40 (-0.36%)
HAE : 107.45 (-2.37%)
SNN : 50.57 (+2.37%)
HRC : 109.64 (-2.81%)
Zimmer Biomet Rides on Product Launches Despite Pricing Woes

Zimmer Biomet's (ZBH) execution of its priority agenda including quality remediation, supply recovery efforts and product introductions looks impressive.

HAE : 107.45 (-2.37%)
HRC : 109.64 (-2.81%)
MDT : 119.26 (-1.41%)
ZBH : 147.80 (-1.14%)
Medtronic (MDT) Gets FDA Nod for Micra AV to Treat AV Block

Medtronic's (MDT) Micra AV cleared by the FDA for the treatment of AV block in patients eligible for pacemaker implantation.

MDT : 119.26 (-1.41%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
MYO : 0.32 (-3.03%)
Hill-Rom (HRC) Gains Ground on Global Expansion, New Menu

Hill-Rom (HRC) is optimistic about its latest buyouts of Breathe Technologies and Voalte, mirroring its outstanding capital management strategy in turn.

OMCL : 84.05 (-2.44%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
MDT : 119.26 (-1.41%)
ResMed Launches AirFit F30i CPAP Mask, Widens Client Base

ResMed (RMD) launches its first tube-up, full-face CPAP mask, thus completing its full-face mask portfolio.

CERN : 74.46 (-1.61%)
MDT : 119.26 (-1.41%)
RMD : 162.39 (+0.62%)
HAE : 107.45 (-2.37%)
Here's Why You Should Retain Edwards Lifesciences Stock Now

Investors can hold on to Edwards Lifesciences (EW) in their portfolio for now, thanks to solid prospects.

OMCL : 84.05 (-2.44%)
EW : 230.45 (-0.35%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
Cardiovascular Systems (CSII) Stock Hits New 52-Week High

Cardiovascular Systems (CSII) is optimistic about maintaining its growth momentum on several recent developments.

CSII : 51.34 (-2.82%)
MDT : 119.26 (-1.41%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade HAE with:

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

2nd Resistance Point 111.41
1st Resistance Point 109.43
Last Price 107.45
1st Support Level 106.17
2nd Support Level 104.89

See More

52-Week High 140.36
Fibonacci 61.8% 117.39
Fibonacci 50% 110.30
Last Price 107.45
Fibonacci 38.2% 103.20
52-Week Low 80.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar